A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index

Fertility and Sterility

Volumn 93, Issue 6, 2010, Pages 2084-2087

  Kahraman, Semra ^a   Karlikaya, Guvenc ^a   Kavrut, Mustecep ^a   Karagozoglu, Hale ^a  

^a MEMORIAL HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; LEUPRORELIN; RECOMBINANT CHORIONIC GONADOTROPIN;

ARTICLE; BODY MASS; CHEMOLUMINESCENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; EMBRYO; EMBRYO TRANSFER; FEMALE; FERTILIZATION; HUMAN; INFERTILITY THERAPY; METAPHASE; OOCYTE; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SERUM; TRANSVAGINAL ECHOGRAPHY;

ADULT; BODY MASS INDEX; CHORIONIC GONADOTROPIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLICULAR FLUID; HUMANS; OBESITY; OOCYTE RETRIEVAL; OOCYTES; OVERWEIGHT; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS; REPRODUCTIVE TECHNIQUES, ASSISTED; TREATMENT OUTCOME;

EID: 77949915595     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.08.026     Document Type: Article

References (15)

1. Salha O., Dada T., and Sharma V. Influence of body mass index and self-administration of hCH on the outcome of IVF cycles: a prospective cohort study. Hum Fertil 4 (2001) 37-42
2. Driscoll G.L., Tyler J.P.P., Hangan J.T., Fisher P.R., Birdsall M.A., and Knight D.C. A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. Hum Reprod 15 (2000) 1305-1310
3. Chang P., Kenley S., Burns T., Denton G., Currie K., DeVane G., et al. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel®) to urinary hCG (Profasi®) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril 76 (2001) 67-74
4. The European Recombinant Human Chorionic Gonadotrophin Study Group. Induction of final follicular maturation and early luteinization in woman undergoing ovulation induction for assisted reproduction treatment-recombinant HCG versus urinary HCG. Hum Reprod 15 (2000) 1446-1451
5. Al-Inany H., Aboulghar M.A., Mansour R.T., and Proctor M. Recombinant versus urinary gonadotrophins for triggering ovulation in assisted conception. Hum Reprod 20 (2005) 2061-2073
6. The International Recombinant Human Chorionic Gonadotropin Study Group. Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG. Fertil Steril 75 (2001) 1111-1118
7. Kovacs P., Kovats T., Bernard A., Zadori J., Szmatona G., and Kaali S.G. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization. Fertil Steril 90 (2008) 2133-2137
8. Chan C.C.W., Ng E.H.Y., Tang O.S., Yeung W.S.B., Lau E.Y.L., and Ho P.C. A prospective, randomized, double-blind study to compare two doses of recombinant human chorionic gonadotropin in inducing final oocyte maturity and the hormonal profile during the luteal phase. J Clin Endocrinol Metab 90 (2005) 3933-3938
9. Harlass F.F., Plymate S.R., Fariss B.L., and Belts R.P. Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female. Fertil Steril 42 (1984) 649-652
10. Hollmann M., Runnebaum B., and Gerhard I. Effects of weight loss on the hormonal profile in obese, infertile women. Hum Reprod 11 (1996) 1884-1891
11. Fedorcsak P., Dale P.O., Storeng R., Ertzeid G., Bjercke S., Oldereid N., et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 19 (2004) 2523-2528
12. Wang J.X., Davies M., and Norman R.J. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ 321 (2000) 1320-1321
13. Lashen H., Ledger W., Bernal A.L., and Barlow D. Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization. Hum Reprod 14 (1999) 712-715
14. Dechaud H., Anahory T., Reyftmann L., Loup V., Hamamah S., and Hedon B. Obesity does not adversely affect results in patients who are undergoing in vitro fertilization and embryo transfer. Euro J Obstet Gynecol Reprod Biol 127 (2006) 88-93
15. Esinler I., Bozdaǧ G., and Yarali H. Impact of isolated obesity on ICSI outcome. RBM Online 17 (2008) 583-587